RxDoctor Payments Data

Darren Adams, DO

Obstetrics & Gynecology · Portsmouth, OHNPI 1770549024

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,610 of the $32,712 with a category attached, or 75.2%. 9 manufacturers reported payments, led by AbbVie at 48.5% of the total. Reporting peaked in 2019 at $16,986 and has fallen 98.7% since, to $223 in 2025. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,712in general payments, 2019–2025

Across 99 payments — averaging $330.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$16K
  • Pacira Pharmaceuticals Incorporated$13K
  • Medical Device Business Services, Inc.$2K
  • Johnson & Johnson$1K
  • Hologic Sales And Service, LLC$369
  • Pfizer$99
  • plus $147 from 3 others

What the payments were for

  • Speaking & faculty fees$24,61075%
  • Travel & lodging$5,16216%
  • Food & beverage$2,9409%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,712 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.

See all obstetrics & gynecology providers in Ohio

Medicare billing

Part B allowed, 2024
$12,367
Medicare patients
63
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol87$1,486
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip35$424
Acyclovir23$267
Metronidazole23$229
Levothyroxine Sodium24$212
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$130
Fluconazole26$117
Clonazepam14$83
Azithromycin14$21

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Portsmouth

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →